You are viewing an incomplete version of our website. Please click to reload the website as full version.

Quinoid Dihydropteridine Reductase (QDPR) (C-Term) Peptide

Details for Product No. ABIN698468, Supplier: Log in to see
Protein Name
  • 2610008L04Rik
  • CG4665
  • D5Ertd371e
  • DDBDRAFT_0168923
  • DDBDRAFT_0237752
  • DDB_0168923
  • DDB_0237752
  • Dhpr
  • DHPR
  • Dmel\\CG4665
  • MGC131372
  • PKU2
  • QDPR
  • qdpr
  • SDR33C1
Protein Region
Peptide Type
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Specificity The synthetic peptide sequence used to generate the antibody AP8841b was selected from the C-term region of human QDPR. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Background QDPR is the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems.
Restrictions For Research Use only
Storage 4
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Schnetz-Boutaud, Anderson, Brown et al.: "Examination of tetrahydrobiopterin pathway genes in autism." in: Genes, brain, and behavior, Vol. 8, Issue 8, pp. 753-7, 2009 (PubMed).